#9500
Leishmania infantum IgG ELISA
ELISA kit for the diagnosis of human and canine visceral
leishmanioses
Lot 2327L (Expiry date: 03.05.2025)
Production date : 04.09.2023
Results of quality control 2 (after 6
months), date: 28.02.2024
No serum blank (average) : 0.113
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.019 |
0.012 |
-0.013 |
0.019 |
0.000 |
0 |
Negative control serum
(N° 9500-06) |
0.021 |
0.077 |
0.024 |
0.096 |
0.055 |
3 |
Weak positive serum
(N° 9500-07) |
0.420 |
0.425 |
0.418 |
0.443 |
0.427 |
22 |
Positive control serum
(N° 9500-08) |
1.838 |
1.986 |
1.906 |
2.066 |
1.949 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9500-08 |
> 1.200 |
1.949 |
Yes |
Absorbance of weak positive serum 9500-07, as % of positive serum
|
> 10 %
|
22 % |
Yes |
Absorbance of negative serum 9500-06, as % of positive serum |
< 8 % |
3 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.113 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|